Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin in Glabellar Frown Lines
NCT00430963Phase 3Completed
- Sponsor
- Merz
- Start
- Oct 2006
- Primary completion
- Apr 2007
- Countries
- 1
01
Overview
A Phase 3 trial of incobotulinumtoxinA in glabellar rhytides, sponsored by Merz. Started Oct 2006; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
glabellar rhytides
Beyond the preview
Go deeper on NCT00430963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430963.